MedTest Dx FDA-approved quantitative test for G6PD

Create PDF

“Unless the patient has a medical episode that uncovers it, most people are unaware that they have the G6PD deficiency,” Keely E Harris, president of the g6pd Deficiency Foundation, said in the release. “Physicians having the knowledge of a patient’s G6PD status provides them a complete picture as they choose and monitor therapies.”

MedTest Dx’s G6PD assay is designed to run concurrently with standard diagnostic tests, such as hemoglobin determination, on a range of analyzers. On-board lysis provides results in minutes.